brett monia ionis pharmaceuticals inc profile  biography  bloomberg feedback brett monia senior vpantisense drug discovery ionis pharmaceuticals inc career history senior vpantisense drug discovery ionis pharmaceuticals inc present senior vpdrug discovery isis pharmaceuticals inc  vpdrug discovery isis pharmaceuticals inc  vppreclinical drug discovery isis pharmaceuticals inc  various positions isis pharmaceuticals inc  show more website wwwionispharmacom corporate information address  gazelle court carlsbad ca  united states phone  fax  web url wwwionispharmacom from the web sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data brett monia  isis pharmaceuticals  inc  zoominfocom browse researchers for full functionality of researchgate it is necessary to enable javascript here are the instructions how to enable javascript in your web browser browse researchers alphabetically by name this directory shows researcher profiles and public profiles as a public profile owner you can opt out from being listed here by changing your privacy settings you can also find profiles of researchers related to you a b c d e f g h i j k l m n o p q r s t u v w x y z other directory results for a alexandre gbechoevi to a  a alexandre gbechoevi  abada khairy abada lyes  abbott el abbott eleanor  abdelazim ibrahim abdelazim ibrahim  abdollahzadeh leila abdollahzadeh m  abdullah mohanad abdullah mohd  abesser corinna abessi ahad  aboulfadl mehdi aboulfadl ragia  abu hmeidan jareer abu hour yousef  acevedo cárdenas francisco xavier acevedo duque albeiro  acquaye aaron acquaye adolf  adams rachel adams rachel  adelle camilla adelli archana  aditya dion aditya dipta  af lara af latifa  agarwal anish agarwal anisha  aghbolaghi reza aghchai abdolhossein  agui juan agui juan  ahad mohammed ahad mohd  ahmad naveed ahmad naveed  ahmed eman ahmed eman  ahmed zehra ahmed zein  aina emran aina farah  akaha  akahad now  akht mo akhta ayee  akponah ejiro akponah precious  al hashmi haitham al hashmi hamood  aldaasin khaled aldabaeen faisal  alrikabi hashim alrikabi hussein  alali mohammed jasim alali mohsen  alate chaitanya alate monika  albertson daniel albertson dawn  alderman delorus alderman delton  alex sandy alex savatovsky  alford keith a alford kimberly  alhussein saad alhussein shalimar  ali mutari hajara ali mutaz  alina dumitru alina emma  alkhoury ziad alkhoushi najla  allen tara allen tara  almeida figueroa leonor almeida filho antonio  alnasr modi alnasr qasem  alqowaifly lolowah alqoyus walu  alsheikhhussain areej alsheikha nour  altuntas muhammed altuntas muhammed  alves barbosa marcela alves barbosa weider  alzoubi mohammad alzoubi mohammed  amato mark amato marta  amighi fatemeh amighi karim  ammen sean ammen sue  an junyoung an justin  anca andreea anca anton  anderson ld anderson lea  andrade mariane andrade mariano  andrianto sonny andrianto tomy  angelopoulou elthina angelopoulou fotini  anka an anka ann  antalek brian antalek mitchell  antunes filipe antunes filipe  ape francesca ape hendra  arab raed arab rahim  araujo camilo araujo carla  arcila angela arcila annelisa  argiro renato argiro salvatore  arismendy mira julian esteban arismendy morales juan  armstronggibbs fiona armstronggregson julie  arouri ahmad arouri faten  arsovasarafinovska zorica arsovic marjan  aryatnie yuly aryava parsi ardavan  asfaw asfawossen asfaw asrat  ashwell ellie ashwell felipe  asroni imam asror ibnu  atalay betul atalay bora  atkinsonhope gary atkinsonleadbeater karen  audi winston audia ale  austin vivienne austin walter  avit gaspar avit geoffrey  ayala ramírez juan ayala rendon carolina  ayoub fadi ayoub fadi  azevedo mario azevedo marisa  a    researchgate gmbh all rights reservedabout us · help center · careers · developers · news · contact us · privacy · terms · copyright  advertising · recruiting ordiscover by subject areajoin for freelog in researchgate is the professional network for scientists and researchers join for free an error occurred while rendering template rgreqfbfeeecdfad false brett p monia phd  ionis pharmaceuticals brett p monia phd senior vice president antisense drug discovery dr monia is a founding member of ionis and senior vice president of antisense drug discovery dr monia is also the franchise leader for programs in oncology and rare genetic diseases at ionis pharmaceuticals as head of drug discovery dr monia is responsible for establishing strategic directions for preclinical drug discovery research focused on rnadirected therapeutic platforms establishment and supervision of early clinical development strategies through clinical proofofconcept and coordinating research activities with clinical investigators consultants and with corporate partners his contributions include research into the medicinal chemistry and mechanisms of action of oligonucleotidebased drugs in cell culture and in animals and in the establishment of numerous preclinical and clinical programs in various therapeutic areas including oncology metabolic disease inflammation cardiovascular disease and rare diseases programs under dr monia’s direct supervision have resulted in the clinical development of more than twenty antisensebased drugs to date covering areas as diverse as cancer type  diabetes cardiovascular disease asthma and rare genetic diseases dr monia’s publication record exceeds  primary research manuscripts reviews and book chapters and he is an inventor on more than  issued patents in addition dr monia serves on the editorial boards for a number of scientific journals is a member of the american association of cancer research the american diabetes association the american association for the study of liver diseases the american society of hematology and serves on the board of directors for the oligonucleotide therapeutics society dr monia also holds a position as a scientific advisory board member with oncogenex technologies inc and is an adjunct professor of biology at san diego state university where he lectures at the graduate level on pharmacology dr monia received his phd in pharmacology at the university of pennsylvania and bs degrees in molecular biology and analytical chemistry at stockton state college in pomona new jersey about mission  values in the community management board of directors contact patients patient resources clinical trials drug approval process learn more about ionis’ clinical trials pipeline rd antisense technology discovery platform basic science antisense drugs medicinal chemistry antisense approaches intellectual property strategic alliances pharmaceutical partners satellite companies investors  media news  events press releases archived webcasts event calendar corporate governance board of directors board criteria director compensation and board meeting attendance committee composition certificates of incorporation bylaws code of ethics clawback policy rsu holding guidelines annual meeting stock information stock quote stock chart analyst coverage ownership profile financials annual reports sec filings shareholder services investor faq information request press kit careers available positions search open jobs browse open jobs edit your profile view submitted applications culture  values benefits equal opportunity intern program postdoctoral program brett p monia – dynacure – innovative therapies for rare diseases brett p monia brett p monia phd is a founding member of ionis pharmaceuticals ions and the executive officer and senior vice president of antisense drug discovery dr monia is also the franchise leader for programs in oncology and rare genetic diseases at ionis pharmaceuticals as head of drug discovery dr monia is responsible for establishing strategic directions for preclinical drug discovery research establishing and supervising early clinical development strategies through clinical proofofconcept and coordinating research activities with clinical investigators consultants and corporate partners programs under dr monia’s supervision have resulted in the clinical development of more than  antisensebased drugs to date across a broad range of therapeutic areas including multiple marketing approvals dr monia’s publication record exceeds more than  research manuscripts reviews and book chapters and he is the inventor of more than  issued patents dr monia received his phd in pharmacology at the university of pennsylvania and holds bs degrees in molecular biology and analytical chemistry he serves on the editorial boards for numerous scientific journals serves on the board of directors as immediate past president of the oligonucleotide therapeutics society and is an adjunct professor of biology at san diego state university copyright    dynacure  all rights reserved supervisory board – dynacure – innovative therapies for rare diseases supervisory board copyright    dynacure  all rights reserved ﻿ ionis pharmaceuticals inc nasdaqions given outperform rating at bmo capital markets  chaffey breeze daily ratings  news for ionis pharmaceuticals inc complete the form below to receive the latest headlines and analysts recommendationsfor ionis pharmaceuticals inc with our free daily email newsletter follow chaffeybreeze recent posts morgan stanley reaffirms overweight rating for the charles schwab corporation schw ionis pharmaceuticals inc nasdaqions given outperform rating at bmo capital markets celanese corporation’s ce “neutral” rating reaffirmed at ubs ag benefitfocus inc nasdaqbnft downgraded to “hold” at bidaskclub total sa fp pt set at € by kepler capital markets asahi kasei corp ahksy stock rating upgraded by zacks investment research acadia healthcare company inc achc upgraded by zacks investment research to buy wells fargo  company reiterates outperform rating for alder biopharmaceuticals inc aldr albemarle corporation to post fy earnings of  per share jefferies group forecasts nysealb insider selling nakama group plc nak insider sells £ in stock innoviva inc nasdaqinva shares bought by ameritas investment partners inc sei investments co has  stake in ilg inc nasdaqilg great west life assurance co can holds position in infinera corporation nasdaqinfn swiss national bank continues to hold position in green plains inc nasdaqgpre idera pharmaceuticals inc nasdaqidra shares sold by jpmorgan chase  co ameriprise financial inc has  million position in iacinteractivecorp nasdaqiac jpmorgan chase  co cuts stake in home bancshares inc nasdaqhomb btim corp invests  in vertex pharmaceuticals incorporated nasdaqvrtx quest diagnostics incorporated dgx rating lowered to hold at bidaskclub q  eps estimates for public storage psa reduced by analyst ionis pharmaceuticals inc nasdaqions given outperform rating at bmo capital markets posted by lucas kauffman on jul th   no comments ionis pharmaceuticals inc nasdaqions‘s stock had its “outperform” rating restated by investment analysts at bmo capital markets in a report released on tuesday they presently have a  target price on the stock bmo capital markets’ price objective would suggest a potential upside of  from the company’s previous close other analysts also recently issued reports about the stock needham  company llc reiterated a “buy” rating and issued a  price objective on shares of ionis pharmaceuticals in a research report on wednesday may th piper jaffray companies set a  price objective on shares of ionis pharmaceuticals and gave the company a “buy” rating in a research report on wednesday may th zacks investment research upgraded shares of ionis pharmaceuticals from a “hold” rating to a “buy” rating and set a  price objective on the stock in a research report on wednesday july th thestreet raised shares of ionis pharmaceuticals from a “d” rating to a “c” rating in a research note on wednesday july th finally stifel nicolaus reissued a “hold” rating and set a  target price on shares of ionis pharmaceuticals in a research note on monday july th three analysts have rated the stock with a sell rating six have assigned a hold rating and seven have given a buy rating to the stock ionis pharmaceuticals currently has an average rating of “hold” and a consensus target price of  get ionis pharmaceuticals inc alerts shares of ionis pharmaceuticals nasdaqions traded down  on tuesday hitting   shares of the stock were exchanged ionis pharmaceuticals has a one year low of  and a one year high of  the firm’s  day moving average price is  and its  day moving average price is  the firm’s market cap is  billion ionis pharmaceuticals nasdaqions last issued its quarterly earnings data on tuesday may th the company reported  earnings per share for the quarter beating the thomson reuters’ consensus estimate of  by  the firm had revenue of  million for the quarter compared to the consensus estimate of  million ionis pharmaceuticals had a negative net margin of  and a negative return on equity of  ionis pharmaceuticals’s quarterly revenue was up  compared to the same quarter last year during the same period last year the firm posted  eps equities analysts anticipate that ionis pharmaceuticals will post  earnings per share for the current year trademark violation notice this article was first published by chaffey breeze and is owned by of chaffey breeze if you are accessing this article on another domain it was illegally stolen and reposted in violation of international copyright law the original version of this article can be read at httpswwwchaffeybreezecomionispharmaceuticalsincnasdaqionsgivenoutperformratingatbmocapitalmarketshtml in related news svp patrick r o’neil sold  shares of the firm’s stock in a transaction that occurred on monday may st the shares were sold at an average price of  for a total transaction of  following the completion of the sale the senior vice president now directly owns  shares in the company valued at  the transaction was disclosed in a filing with the sec which is accessible through the sec website also chairman stanley t crooke sold  shares of the firm’s stock in a transaction that occurred on thursday july th the stock was sold at an average price of  for a total transaction of  following the sale the chairman now owns  shares of the company’s stock valued at  the disclosure for this sale can be found here over the last three months insiders sold  shares of company stock worth   of the stock is currently owned by insiders hedge funds have recently bought and sold shares of the company canada pension plan investment board boosted its stake in ionis pharmaceuticals by  in the first quarter canada pension plan investment board now owns  shares of the company’s stock valued at  after buying an additional  shares in the last quarter janney montgomery scott llc boosted its stake in ionis pharmaceuticals by  in the first quarter janney montgomery scott llc now owns  shares of the company’s stock valued at  after buying an additional  shares in the last quarter candriam luxembourg sca boosted its stake in ionis pharmaceuticals by  in the first quarter candriam luxembourg sca now owns  shares of the company’s stock valued at  after buying an additional  shares in the last quarter boston advisors llc bought a new stake in ionis pharmaceuticals during the first quarter valued at approximately  finally blbb advisors llc boosted its stake in ionis pharmaceuticals by  in the first quarter blbb advisors llc now owns  shares of the company’s stock valued at  after buying an additional  shares in the last quarter institutional investors and hedge funds own  of the company’s stock ionis pharmaceuticals company profile ionis pharmaceuticals inc is engaged in discovering and developing ribonucleic acid rnatargeted therapeutics the company using its drug discovery platform has developed a pipeline of drugs for patients with unmet medical needs the company’s segments include ionis core and akcea therapeutics in the ionis core segment the company is engaged in exploiting a drug discovery platform to generate a pipeline of drugs for the company and its partners receive news  ratings for ionis pharmaceuticals inc daily  enter your email address below to receive a concise daily summary of the latest news and analysts ratings for ionis pharmaceuticals inc and related companies with marketbeatcoms free daily email newsletter latest news leave a reply click here to cancel reply name required mail will not be published required website brett p monia  patents   free patent keyword monitoring and additional free benefits register now for free         browse inventors a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z     search freshpatents       online background check brett p monia patentsrecent bibliographic sampling of brett p monia patents listedpublished in the public domain by the uspto uspto patent application title     modulation of factor  expressiondisclosed herein are antisense compounds and methods for decreasing factor  and treating or preventing thromboembolic complications in an individual in need thereof examples of disease conditions that can be ameliorated with the administration of antisense compounds targeted to factor  include thrombosis embolism and thromboembolism such as deep vein inventors susan m freier chenguang zhao brett p monia hong zhang jeffrey r crosby andrew m siwkowski ionis pharmaceuticals inc    modulation of transthyretin expressionprovided herein are methods compounds and compositions for reducing expression of transthyretin mrna and protein in an animal such methods compounds and compositions are useful to treat prevent delay or ameliorate transthyretin amyloidosis or a symptom thereof inventors brett p monia susan m freier andrew m siwkowski shuling guo ionis pharmaceuticals inc    methods and compositions for modulating alpha antitrypsin expressiondisclosed herein are methods for decreasing aat mrna and protein expression and treating ameliorating preventing slowing progression or stopping progression of fibrosis disclosed herein are methods for decreasing aat mrna and protein expression and treating ameliorating preventing slowing progression or stopping progression of liver disease such as aatd associated liver inventors brett p monia michael l mccaleb susan m freier shuling guo ionis pharmaceuticals inc    compounds and methods for modulating gene expressionthe present disclosure describes short antisense compounds including such compounds comprising chemicallymodified highaffinity monomers  monomers in length certain such short antisense compound are useful for the reduction of target nucleic acids andor proteins in cells tissues and animals with increased potency and improved therapeutic index thus provided herein are inventors sanjay bhanot richard s geary robert mckay brett p monia punit p seth andrew m siwkowski eric e swayze edward wancewicz isis pharmaceuticals inc    oligomeric compounds comprising bicyclic nucleosides and uses thereofthe present invention provides oligomeric compounds certain such oligomeric compounds are useful for hybridizing to a complementary nucleic acid including but not limited to nucleic acids in a cell in certain embodiments hybridization results in modulation of the amount activity or expression of the target nucleic acid in a cell inventors punit p seth susan m freier brett p monia eric e swayze isis pharmaceuticals inc    modulation of transthyretin expressionprovided herein are methods compounds and compositions for reducing expression of transthyretin mrna and protein in an animal such methods compounds and compositions are useful to treat prevent delay or ameliorate transthyretin amyloidosis or a symptom thereof inventors brett p monia susan m freier andrew m siwkowski shuling guo isis pharmaceuticals inc    methods and compositions for modulating alphaantitrypsin expressiondisclosed herein are methods for decreasing aiat mrna and protein expression and treating ameliorating preventing slowing progression or stopping progression of fibrosis disclosed herein are methods for decreasing aiat mrna and protein expression and treating ameliorating preventing slowing progression or stopping progression of liver disease such as aiatd associated liver inventors brett p monia michael l mccaleb susan m freier shuling guo isis pharmaceuticals inc    compounds and methods for modulating expression apobthe present disclosure describes short antisense compounds including such compounds comprising chemicallymodified highaffinity monomers  monomers in length certain such short antisense compound are useful for the reduction of target nucleic acids andor proteins in cells tissues and animals with increased potency and improved therapeutic index thus provided herein are inventors sanjay bhanot richard s geary robert mckay brett p monia punit p seth andrew m siwkowski eric e swayze edward wancewicz isis pharmaceuticals inc    chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometrythe present invention relates to novel chimeric oligomeric compounds having a plurality of alternating regions having either rna like having northern or ′endo conformational geometry ′endo regions or dna like having southern or c′endoo′endo conformational geometry the oligomeric compounds of the present invention have shown reduction in mrna levels in inventors brett p monia madeline m butler robert mckay brenda f baker isis pharmaceuticals inc    modulation of transthyretin expressionprovided herein are methods compounds and compositions for reducing expression of transthyretin mrna and protein in an animal such methods compounds and compositions are useful to treat prevent delay or ameliorate transthyretin amyloidosis or a symptom thereof inventors brett p monia susan m freier andrew m siwkowski shuling guo isis pharmaceuticals inc    antisense oligonucleotide modulation of raf gene expressionoligonucleotides are provided which are targeted to nucleic acids encoding human raf and capable of inhibiting raf expression the oligonucleotides may have chemical modifications at one or more positions and may be chimeric oligonucleotides methods of inhibiting the expression of human raf using oligonucleotides of the invention are also provided inventors brett p monia     methods for modulating factor  expressiondisclosed herein are methods for decreasing factor  and treating or preventing thromboembolic conditions in an individual in need thereof examples of disease conditions that can be ameliorated with the administration of antisense compounds targeted to factor  include thrombosis embolism and thromboembolism such as deep vein thrombosis pulmonary embolism inventors brett p monia robert a macleod jeffrey r crosby isis pharmaceuticals inc    antidotes to antisense compoundsthe present invention relates to antisense antidote compounds and uses thereof such antidote compounds reduce the magnitude andor duration of the antisense activity of an antisense compound inventors brett p monia andrew m siwkowski hong zhang isis pharmaceuticals inc    modulation of factor  expressiondisclosed herein are antisense compounds and methods for decreasing factor  and treating or preventing thromboembolic complications in an individual in need thereof examples of disease conditions that can be ameliorated with the administration of antisense compounds targeted to factor  include thrombosis embolism and thromboembolism such as deep vein inventors susan m freier brett p monia hong zhang chenguang zhao jeffrey r crosby andrew m siwkowski     modulation of factor  expressiondisclosed herein are antisense compounds and methods for decreasing factor  and treating or preventing thromboembolic complications in an individual in need thereof examples of disease conditions that can be ameliorated with the administration of antisense compounds targeted to factor  include thrombosis embolism and thromboembolism such as deep vein inventors susan m freier brett p monia hong zhang chenguang zhao jeffrey r crosby andrew m siwkowski isis pharmaceuticals inc    compounds and methods for modulating expression of gccrthe present disclosure describes short antisense compounds including such compounds comprising chemicallymodified highaffinity monomers  monomers in length certain such short antisense compound are useful for the reduction of target nucleic acids andor proteins in cells tissues and animals with increased potency and improved therapeutic index thus provided herein are inventors sanjay bhanot richard s geary robert mckay brett p monia punit p seth andrew m siwkowski eric e swayze edward wancewicz isis pharmaceuticals inc    modulation of diacylglycerol acyltransferase  expressioncompounds compositions and methods are provided for modulating the expression of diacylglycerol acyltransferase  the compositions comprise oligonucleotides targeted to nucleic acid encoding diacylglycerol acyltransferase  methods of using these compounds for modulation of diacylglycerol acyltransferase  expression and for diagnosis and treatment of diseases and conditions associated with expression inventors sanjay bhanot kenneth w dobie xingxian yu brett p monia isis pharmaceuticals inc    compositions and their uses directed to aceytlcoa carboxylasesdisclosed herein are compounds compositions and methods for modulating the expression of acc or acc or both in a cell tissue or animal also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders inventors sanjay bhanot brett p monia john g geisler robert mckay kenneth w dobie isis pharmaceuticals inc    antisense oligonucleotide modulation of raf gene expressionoligonucleotides are provided which are targeted to nucleic acids encoding human raf and capable of inhibiting raf expression the oligonucleotides may have chemical modifications at one or more positions and may be chimeric oligonucleotides methods of inhibiting the expression of human raf using oligonucleotides of the invention are also provided inventors brett p monia isis pharmaceuticals inc    modulation of diacylglycerol acyltransferase  expressioncompounds compositions and methods are provided for modulating the expression of diacylglycerol acyltransferase  the compositions comprise oligonucleotides targeted to nucleic acid encoding diacylglycerol acyltransferase  methods of using these compounds for modulation of diacylglycerol acyltransferase  expression and for diagnosis and treatment of disease associated with expression of diacylglycerol inventors brett p monia mark j graham isis pharmaceuticals inc    modulation of factor  expressiondisclosed herein are antisense compounds and methods for decreasing factor  and treating or preventing thromboembolic complications in an individual in need thereof examples of disease conditions that can be ameliorated with the administration of antisense compounds targeted to factor  include thrombosis embolism and thromboembolism such as deep vein inventors susan m freier brett p monia hong zhang jeffrey r crosby chenguang zhao isis pharmaceuticals inc    compounds and methods for modulating expression of gcgrthe present disclosure describes short antisense compounds including such compounds comprising chemicallymodified highaffinity monomers  monomers in length certain such short antisense compound are useful for the reduction of target nucleic acids andor proteins in cells tissues and animals with increased potency and improved therapeutic index thus provided herein are inventors sanjay bhanot richard s geary robert mckay brett p monia punit p seth andrew m siwkowski eric e swayze edward wancewicz isis pharmaceuticals inc    modulation of sglt expressioncompounds compositions and methods are provided for modulating the expression of sglt the compositions comprise oligonucleotides targeted to nucleic acid encoding sglt methods of using these compounds for modulation of sglt expression and for diagnosis and treatment of diseases and conditions associated with expression of sglt are provided inventors susan m freier edward wancewicz brett p monia andrew m siwkowski lynnetta watts thomas a leedom isis pharmaceuticals inc    antisense inhibition via rnase hindependent reduction in mrnathe present invention provides compositions and methods for reducing levels of a preselected mrna using antisense compounds targeted to a splice site or a region up to  nucleobases upstream of an exonintron junction on said mrna preferably said antisense compounds do not elicit rnase h cleavage of the mrna inventors brett p monia susan m freier muthiah manoharan william a gaarde richard h griffey eric e swayze c frank bennett isis pharmaceuticals inc    antisense oligonucleotide modulation of raf gene expressionoligonucleotides are provided which are targeted to nucleic acids encoding human raf and capable of inhibiting raf expression the oligonucleotides may have chemical modifications at one or more positions and may be chimeric oligonucleotides methods of inhibiting the expression of human raf using oligonucleotides of the invention are also provided inventors brett p monia isis pharmaceuticals inc    compositions and their uses directed to hepcidindisclosed herein are compounds compositions and methods for modulating the expression of hepcidin in a cell tissue or animal or preventing ameliorating or treating anemia also provided are methods for prevention amelioration or treatment of anemia and for increasing red blood cell count in an animal also provided are methods inventors brett p monia c frank bennett william a gaarde trisha lockhart robert mckay isis pharmaceuticals inc    modulation of inflammatory responses by factor xidisclosed herein are antisense compounds and methods for modulating factor xi and modulating an inflammatory disease disorder or condition in an individual in need thereof inflammatory diseases in an individual such as arthritis and colitis can be ameliorated or prevented with the administration of antisense compounds targeted to factor xi inventors brett p monia jeffrey r crosby robert a macleod susan m freier isis pharmaceuitcals inc    antisense modulation of ptpb expressioncompounds compositions and methods are provided for modulating the expression of ptpb the compositions comprise antisense compounds particularly antisense oligonucleotides targeted to nucleic acids encoding ptpb methods of using these compounds for modulation of ptpb expression and for treatment of diseases associated with expression of ptpb are provided inventors sanjay bhanot lex m cowsert jacqueline r wyatt brett p monia madelline m butler robert mckay susan m freier kenneth w dobie isis pharmaceuticals inc    compositions and their uses directed to diacylglycerol acyltransferase disclosed herein are compounds compositions and methods for modulating dgat activity preferably the expression of dgat from a nucleic acid is inhibited methods are provided for treating ameliorating or treating liver fibrosis either directly or by treating an underlying etiological factor preferably the treatment amelioration or prevention comprises administering a inventors xingxian yu sanjay bhanot brett p monia isis pharmaceuticals inc    modulation of transthyretin expressionprovided herein are methods compounds and compositions for reducing expression of transthyretin mrna and protein in an animal such methods compounds and compositions are useful to treat prevent delay or ameliorate transthyretin amyloidosis or a symptom thereof inventors brett p monia susan m freier andrew m siwkowski     modulation of transthyretin expression for the treatment of cns related disorderscompounds compositions and methods are provided for modulating the expression of transthyretin in the brain specifically the choroid plexus the compositions comprise oligonucleotides targeted to nucleic acid encoding transthyretin methods of using these compounds for modulation of transthyretin expression and for diagnosis and treatment of diseases and conditions associated with inventors richard alan smith brett p monia isis pharmaceuticals inc    enhanced antisense oligonucleotidesdescribed herein are gapwidened antisense oligonucleotides having improved therapeutic index as compared to  moe gapmer antisense oligonucleotides of the same sequence also described are methods of reducing a target rna in an animal using the gapwidened antisense oligonucleotides of the present invention further are methods for selecting a gapwidened inventors brett p monia andrew m siwkowski sanjay bhanot isis pharmaceuticals inc    methods for modulating expression of crebmethods are provided for modulating creb by administering a crebspecific modulator also provided are methods for treating cardiovascular and metabolic disorders in a subject or delaying or preventing risk factors thereof through the modulation of creb the present invention is also directed to methods of decreasing lipid levels in a inventors gerald shulman sanjay bhanot xingxian yu brett p monia     conjugates for use in hepatocyte free uptake assaysthe present invention provides methods of identifying oligomeric compounds such as sirna and doublestranded rna compounds having bioactivity in vivo and kits inventors c frank bennett robert mckay brett p monia brenda f baker namir sioufi isis pharmaceuticals inc    compositions and their uses directed to aceytlcoa carboxylasesdisclosed herein are compounds compositions and methods for modulating the expression of acc or acc or both in a cell tissue or animal also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders inventors sanjay bhanot brett p monia john geisler robert mckay kenneth w dobie isis pharmaceuticals inc    methods for modulating expression of rbpmethods are provided for modulating rbp by administering a rbpspecific modulator also provided are methods for treating cardiovascular and metabolic disorders in a subject or delaying or preventing risk factors thereof through the modulation of rbp the present invention is also directed to methods of decreasing lipid levels in a inventors brett p monia xingxian yu sanjay bhanot isis pharmaceuticals inc    modulation of factor  expressiondisclosed herein are antisense compounds and methods for decreasing factor  and increasing clotting time in an individual in need thereof examples of disease conditions that can be ameliorated with the administration of antisense compounds targeted to factor  include thrombosis embolism thromoboembolism such as deep vein thrombosis pulmonary embolism inventors susan m freier brett p monia hong zhang chenguang zhao isis pharmaceuticals inc    antidotes to antisense compoundsthe present invention relates to antisense antidote compounds and uses thereof such antidote compounds reduce the magnitude andor duration of the antisense activity of an antisense compound inventors brett p monia andrew m siwkowski hong zhang isis pharmaceutical inc    modulation of sglt expressioncompounds compositions and methods are provided for modulating the expression of sglt the compositions comprise oligonucleotides targeted to nucleic acid encoding sglt methods of using these compounds for modulation of sglt expression and for diagnosis and treatment of diseases and conditions associated with expression of sglt are provided inventors susan m freier edward wancewicz brett p monia andrew m siwkowski lynnetta watts thomas a leedom isis pharmaceuticals inc    modulation of diacylglycerol acyltransferase  expressioncompounds compositions and methods are provided for modulating the expression of diacylglycerol acyltransferase  the compositions comprise oligonucleotides targeted to nucleic acid encoding diacylglycerol acyltransferase  methods of using these compounds for modulation of diacylglycerol acyltransferase  expression and for diagnosis and treatment of diseases and conditions associated with expression     modulation of factor  expressiondisclosed herein are antisense compounds and methods for decreasing factor  and treating or preventing thromboembolic complications hyperproliferative disorders or inflammatory conditions in an individual in need thereof examples of disease conditions that can be ameliorated with the administration of antisense compounds targeted to factor  include thrombosis embolism and     modulation of glucocorticoid receptor expressioncompounds compositions and methods are provided for modulating the expression of glucocorticoid receptor the compositions comprise antisense compounds particularly antisense oligonucleotides which have particular in vivo properties targeted to nucleic acids encoding glucocorticoid receptor methods of using these compounds for modulation of glucocorticoid receptor expression and for treatment of diseases     modulation of factor  expressiondisclosed herein are antisense compounds and methods for decreasing factor  and treating or preventing thromboembolic complications in an individual in need thereof examples of disease conditions that can be ameliorated with the administration of antisense compounds targeted to factor  include thrombosis embolism and thromboembolism such as deep vein     antisense modulation of connective tissue growth factor expressionantisense compounds compositions and methods are provided for modulating the expression of connective tissue growth factor the compositions comprise antisense compounds particularly antisense oligonucleotides targeted to nucleic acids encoding connective tissue growth factor methods of using these compounds for modulation of connective tissue growth factor expression and for treatment of     compounds and methods for modulating expression of crpthe present disclosure describes short antisense compounds including such compounds comprising chemicallymodified highaffinity monomers  monomers in length certain such short antisense compound are useful for the reduction of target nucleic acids andor proteins in cells tissues and animals with increased potency and improved therapeutic index thus provided herein are     compounds and methods for modulating expression of sgltthe present disclosure describes short antisense compounds including such compounds comprising chemicallymodified highaffinity monomers  monomers in length certain such short antisense compound are useful for the reduction of target nucleic acids andor proteins in cells tissues and animals with increased potency and improved therapeutic index thus provided herein are     compounds and methods for modulating expression of ptpbthe present disclosure describes short antisense compounds including such compounds comprising chemicallymodified highaffinity monomers  monomers in length certain such short antisense compound are useful for the reduction of target nucleic acids andor proteins in cells tissues and animals with increased potency and improved therapeutic index thus provided herein are     compounds and methods for modulating expression of gccrthe present disclosure describes short antisense compounds including such compounds comprising chemicallymodified highaffinity monomers  monomers in length certain such short antisense compound are useful for the reduction of target nucleic acids andor proteins in cells tissues and animals with increased potency and improved therapeutic index thus provided herein are     compounds and methods for modulating expression apobthe present disclosure describes short antisense compounds including such compounds comprising chemicallymodified highaffinity monomers  monomers in length certain such short antisense compound are useful for the reduction of target nucleic acids andor proteins in cells tissues and animals with increased potency and improved therapeutic index thus provided herein are     compounds and methods for modulating expression of gcgrthe present disclosure describes short antisense compounds including such compounds comprising chemicallymodified highaffinity monomers  monomers in length certain such short antisense compound are useful for the reduction of target nucleic acids andor proteins in cells tissues and animals with increased potency and improved therapeutic index thus provided herein are     compounds and methods for modulating expression of pcskthe present disclosure describes short antisense compounds including such compounds comprising chemicallymodified highaffinity monomers  monomers in length certain such short antisense compound are useful for the reduction of target nucleic acids andor proteins in cells tissues and animals with increased potency and improved therapeutic index thus provided herein are     compounds and methods for modulating expression of dgatthe present disclosure describes short antisense compounds including such compounds comprising chemicallymodified highaffinity monomers  monomers in length certain such short antisense compound are useful for the reduction of target nucleic acids andor proteins in cells tissues and animals with increased potency and improved therapeutic index thus provided herein are     chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometrythe present invention relates to novel chimeric oligomeric compounds having a plurality of alternating regions having either rna like having northern or ′endo conformational geometry ′endo regions or dna like having southern or c′endoo′endo conformational geometry the oligomeric compounds of the present invention have shown reduction in mrna levels in     antisense modulation of ptpb expressioncompounds compositions and methods are provided for modulating the expression of ptpb the compositions comprise antisense compounds particularly antisense oligonucleotides targeted to nucleic acids encoding ptpb methods of using these compounds for modulation of ptpb expression and for treatment of diseases associated with expression of ptpb are provided     modulation of diacylglycerol acyltransferase  expressioncompounds compositions and methods are provided for modulating the expression of diacylglycerol acyltransferase  the compositions comprise oligonucleotides targeted to nucleic acid encoding diacylglycerol acyltransferase  methods of using these compounds for modulation of diacylglycerol acyltransferase  expression and for diagnosis and treatment of disease associated with expression of diacylglycerol     compositions and their uses directed to diacylglycerol acyltransferase disclosed herein are compounds compositions and methods for modulating dgat activity preferably the expression of dgat from a nucleic acid is inhibited methods are provided for treating ameliorating or treating liver fibrosis either directly or by treating an underlying etiological factor preferably the treatment amelioration or prevention comprises administering a     antisense modulation of ptpb expressioncompositions and methods are provided for decreasing blood glucose levels in an animal or for preventing or delaying the onset of a rise in blood glucose levels in an animal comprising administering to said animal an antisense inhibitor of ptpb expression in combination with at least one glucoselowering drug the ionis pharmaceuticals inc isis pharmaceuticals inc isis pharmaceuitcals inc isis pharmaceuticals inc isis pharmaceuticals inc isis pharmaceutical inc isis phamaceuticals incarchived may have duplicates  we are upgrading our archive   modulation of factor  expression the bibliographic references displayed about brett p monias patents are for a recent sample of brett p monias publicly published patent applications the inventorauthor may have additional bibliographic citations listed at the usptogov freshpatentscom is not associated or affiliated in any way with the authorinventor or the united states patenttrademark office but is providing this noncomprehensive sample listing for educational and research purposes using public bibliographic data published and disseminated from the united states patenttrademark office public datafeed this information is also available for free on the usptogov website if brett p monia filed recent patent applications under another name spelling or location then those applications could be listed on an alternate page if no bibliographic references are listed here it is possible there are no recent filings or there is a technical issue with the listingin that case we recommend doing a search on the usptogov website sign up for the freshpatentscom free keyword monitor and check for keyword phrases ie rfid  wireless web development fuel cells etcyou will be notified when new patent applications and inventions are published that match your keywords also you can save for later research public patentinvention documents using our free organizer it takes only  seconds to sign up or loginadvertise on freshpatentscom  rates  infodesigncode   freshcontext llcfreshpatentscompatent data source patents published by the united states patent and trademark office usptoinformation published here is for researcheducational purposes only and in conjunction with our keyword monitor and is not meant to be used in place of the full uspto patent documentimages or a comprehensive patent archive search complete official applications are on file at the uspto and may contain additional dataimages freshpatentscom is not affiliated with or endorsed by the uspto or firmsindividuals or productsdesignsideas related to listed patents and there may be applicable trademarks or servicemarks within the documentsfreshpatentscom support  terms  conditions ions brett p monia insider trades for ionis pharmaceuticals inc bulletin investor alert tokyo markets open in us market snapshot currencies commodities expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close ionis pharmaceuticals inc nasdaq ions go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus ionis pharmaceuticals inc after hours  quotes are delayed by  min jul    pm ions quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite todays close     change   day low day high    week low  week high   insider activity individual brett p monia dr brett p monia is senior vpdrug discovery  corporate development at ionis pharmaceuticals inc a member at american association for cancer research a member at american diabetes association a member at american association for the study of liver diseases a member at american society of hematology and adjunct professor at san diego state university he is on the board of directors at oligonucleotide therapeutics society inc he received his undergraduate degree from stockton university and a doctorate degree from the university of pennsylvania transactions date shares transaction value     disposition at  per share           disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share           disposition at  per share           disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share           disposition at  per share           disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share           disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share           disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share           disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share           disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share           disposition at  per share      derivativenonderivative trans at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives dr stanley t crooke chairman president  chief executive officer ms b lynne parshall chief operating officer  director ms elizabeth l hougen chief financial officer  senior vpfinance mr patrick r oneil secretary chief compliance officer  svplegal ms paula soteropoulos president  ceoakcea therapeutics dr c frank bennett senior vice presidentantisense research dr brett p monia senior vpdrug discovery  corporate development dr rosanne crooke executive directorcardiovascular diseases dr eugene schneider vice presidentclinical development dr richard s geary senior vice presidentdevelopment ms sarah boyce chief business officer dr d wade walke vpcorporate communications  investor relations mr frederick t muto independent director dr joseph loscalzo independent director mr breaux b castleman independent director mr joseph h wender independent director mr joseph r klein independent director dr spencer r berthelsen independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite tlt quoteszigmancomposite jnug x powered by log in  pm edt july   marketstatecountryus new york after marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pgraham says trump is showing weakness in unilateral public spat with sessions pfacebook hits  billion users earnings beat boosts stock live blog recap pnew rules for ftse russell index provider to exclude snap others from benchmarks pthe nintendo switch’s sellout launch in many charts p coworkers you should avoid like the plague in meetings pcommunity health systems shares fall after profit warning pwhat donald trump’s battle of wills with jeff sessions teaches you about a difficult boss pstock market ends at record on robust earnings as fed issues policy update ptrump puts his hands together for ‘the late great abraham lincoln’ pyear treasury yield falls the most in five weeks after fed statement pfor transgender americans workplace discrimination isn’t limited to the military pyour k match may have some strings attached pthis is the worst mistake people make at work pwhy equalweighted stockmarket indexes bounce back faster from bear markets pnutrisystem shares rally on betterthanexpected earnings pbuffalo wild wings drop  on high chicken wing costs pbreakingf networks shares fall after weak outlook revenue miss pdonald trump is winning the currency cold war pimco pfacebook hits  billion users earnings beat live blog p‘game of thrones’ science let’s take a closer look at that greyscale loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  brett p monias involvement in venture capital via isis pharmaceuticals inc want to see morewant to find out who got funded and who’s funding the next big thing in real time all across the world tailored to your specific areas of focus deals per dayget access to the most exhaustive worldwide funding watch on the webcomprehensive funding informationknow about who invested in a company which sites covered the event the funding history etcexclusive insightsview original analytics such as most dynamic industries most active investors and morestay awareget emailed when deals critical to your business happen filter by region industry and topics of interestas seen onhave a loginsign inregister nowits freeuse your social accountor fill in the quick formregister nowpromise we wont spamsign invia your social accountvia your existing wgf accountremember meregister its freeforgot your passwordsign inforgot your passwordenter your email and we will send you your new passwordreset passwordthe worlds largest funding basepeoplebrettpmoniasectionpeoplesubsectiondetailid search deals by company name industry location investors search brettp moniaget alertedif brett p monia gets fundedbrett p moniaisis pharmaceuticals inc  senior vice president of antisense drug discoverydeals involving brett p monia raised with isis pharmaceuticals inc on october  raised with isis pharmaceuticals inc on november  raised with isis pharmaceuticals inc on september  raised with isis pharmaceuticals inc on december  raised with isis pharmaceuticals inc on august please note that all data is automatically extracted and errors can occurthe whogotfunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and completesome of the profile information was collected using the crunchbase api for more details on the profile please check brett p monia on crunchbaseinaccurate data help us improve whogotfunded post a comment microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft loading your search results  peoplelookercom updating data on  live please help us narrow down your search all states alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming im not sure please enter a full name please help us narrow down your search first name please enter first name last name please enter last name people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again